Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

How Zafgen Inc (ZFGN) Stacks Up Against Its Peers

Page 1 of 2

At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices. Out of thousands of stocks that hedge funds invest in, small-caps can provide the best returns over the long term due to the fact that these companies are less efficiently priced and are usually under the radars of mass-media, analysts and dumb money. This is why we follow the smart money moves in the small-cap space.

Hedge fund interest in Zafgen Inc (NASDAQ:ZFGN) shares was flat during the third quarter. This is usually a negative indicator. 9 hedge funds that we track owned the stock on September 30, same as on June 30. At the end of this article we will also compare ZFGN to other stocks including Akarti Therapeutics PLC (ADR) (NASDAQ:AKTX), Cherokee Inc. (NASDAQ:CHKE), and Fate Therapeutics Inc (NASDAQ:FATE) to get a better sense of its popularity.

Follow Zafgen Inc. (NASDAQ:ZFGN)
Trade (NASDAQ:ZFGN) Now!

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.

medication, pharmacist, shelf, care, pharmaceutical, medical, day, drug, clinic, medicament, drugstore, treatment, ill, smiling, medicine, pharmaceutics, of, hospital,

wavebreakmedia/Shutterstock.com

What does the smart money think about Zafgen Inc (NASDAQ:ZFGN)?

At the end of the third quarter, a total of 9 of the hedge funds tracked by Insider Monkey were long this stock, unchanged from the previous quarter. By comparison, 12 hedge funds held shares or bullish call options in ZFGN heading into this year, which has since fallen by 25%. With hedge funds’ capital changing hands, there exists a few key hedge fund managers who were upping their stakes meaningfully (or already accumulated large positions).

HedgeFundSentimentChart

When looking at the institutional investors followed by Insider Monkey, Anders Hove and Bong Koh’s VHCP Management has the most valuable position in Zafgen Inc (NASDAQ:ZFGN), worth close to $2 million, comprising 2% of its total 13F portfolio. Sitting at the No. 2 spot is Royce & Associates, led by Chuck Royce, holding a $1.7 million position. Some other peers that hold long positions contain Dmitry Balyasny’s Balyasny Asset Management, D E Shaw, one of the biggest hedge funds in the world, and Cliff Asness’ AQR Capital Management. We should note that none of these hedge funds are among our list of the 100 best performing hedge funds, which is based on the performance of their 13F long positions in non-micro-cap stocks.

Page 1 of 2